Modern Diagnostic Reports Q2FY27 IPO Proceeds Utilization; Notes Capex Delays
Modern Diagnostic & Research Centre Ltd 路 Others (Uncategorized) 路 17 Nov 2026, 4:57 pm
Modern Diagnostic Reports Q2FY27 IPO Proceeds Utilization; Notes Capex Delays CARE Ratings' Monitoring Agency Report for Modern Diagnostic & Research Centre shows Rs.32.46 crore of its Rs.36.89 crore IPO proceeds utilized through 30th Sep'26, leaving Rs.4.43 crore unutilized. Capex deployment faced delays against original prospectus timelines, with Rs.16.33 crore spent out of the allocated Rs.20.69 crore. The remaining capex of Rs.4.36 crore will spill into subsequent financial years following board approval on 13th May'26. Additionally, the company's stock price has declined approximately 36.67% from its issue price as of 4th Nov'26.
Original exchange filing (PDF)
More announcements from Modern Diagnostic & Research Centre Ltd
- Financial results along with statement of assets and liabilities for the half year ended 30.09.2026 路 15 Nov 2026
- In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting .... 路 14 Nov 2026
- Intimation of Board meeting under Regulation 29 of the SEBI (LODR) Regulations, 2015 to consider and approve the unaudited financial results for the half year ended 30th September, 2026 路 07 Nov 2026
- Submission of voting results of the 14th AGM of Modern Diagnostic & Research Centre Limited held on Wednesday, 30th September, 2026 路 01 Oct 2026
- Outcome of Proceedings of AGM 路 30 Sept 2026
- Clarification on significant movement in the price of the securities of the company 路 15 Sept 2026
- The Exchange has sought clarification from Modern Diagnostic & Research Centre Ltd on September 15, 2026, with reference to Movement in Price.<BR><BR>The reply is awaited. 路 15 Sept 2026
- Pursuant to Regulations 29, 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the .... 路 05 Sept 2026
